Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Erweiterte Suche bearbeiten
Filter bei nächster Suche beibehalten
publishDate:"[2019 TO 2021]"
collection:"CTG"
topic_facet:"Phase: Phase 3"
topic_facet:"COVID-19"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=publishDate%3A%22%5B2019+TO+2021%5D%22&filter%5B%5D=collection%3A%22CTG%22&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+3%22&filter%5B%5D=topic_facet%3A%22COVID-19%22&join=AND&bool0%5B%5D=AND&lookfor0%5B%5D=%22novel+coronavirus%22+OR+Covid+OR+%22Sars-CoV%22+OR+%22CoV-2%22+OR+ncov&type0%5B%5D=AllFields&op0%5B%5D=OR
/vufind/Search/Results?filter%5B%5D=publishDate%3A%22%5B2019+TO+2021%5D%22&filter%5B%5D=collection%3A%22CTG%22&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+3%22&filter%5B%5D=topic_facet%3A%22COVID-19%22&join=AND&bool0%5B%5D=AND&lookfor0%5B%5D=%22novel+coronavirus%22+OR+Covid+OR+%22Sars-CoV%22+OR+%22CoV-2%22+OR+ncov&type0%5B%5D=AllFields&op0%5B%5D=OR
Search /vufind/Search2/Results?filter%5B%5D=publishDate%3A%22%5B2019+TO+2021%5D%22&filter%5B%5D=collection%3A%22CTG%22&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+3%22&filter%5B%5D=topic_facet%3A%22COVID-19%22&join=AND&bool0%5B%5D=AND&lookfor0%5B%5D=%22novel+coronavirus%22+OR+Covid+OR+%22Sars-CoV%22+OR+%22CoV-2%22+OR+ncov&type0%5B%5D=AllFields&op0%5B%5D=OR
PubPharm (42)
1
A Clinical Study to Assess the Efficacy and Safety of Amizon® Max in the Treatment of Moderate Covid-19, Caused by the SARS-CoV-2 Virus : A Multi-centre, Double-blind, Randomised, Placebo-controlled, Trial to Assess the Efficacy and Safety of Amizon® Max, Manufactured by Farmak JSC, in Combination With Basic Treatment, in Subjects With Moderate Covid-19, Which is Caused by the SARS-CoV-2 Virus
enthalten in:
ClinicalTrials.gov
| 2021
Wird geladen...
2
Efficacy of Vitamin D Supplementation to Prevent the Risk of Acquiring COVID-19 in Healthcare Workers : Efficacy of Vitamin D Supplementation to Prevent the Risk of Acquiring or Evolving Into the Severe Form of COVID-19 in Healthcare Workers Caring for Patients With the Disease. Blinded Randomized Clinical Trial
enthalten in:
ClinicalTrials.gov
| 2021
Wird geladen...
3
Hydroxychloroquine as Post-Exposure Prophylaxis Against COVID-19 Infection : Randomized, Double-Blind, Controlled Trial of Hydroxychloroquine vs Placebo as Post-Exposure Prophylaxis Against COVID-19 Infection
enthalten in:
ClinicalTrials.gov
| 2021
Wird geladen...
4
EPA-FFA to Treat Hospitalised Patients With COVID-19 (SARS-CoV-2) : A Randomised, Double-blind, Placebo Controlled Study of Eicosapentaenoic Acid (EPA-FFA) Gastro-resistant Capsules to Treat Hospitalised Subjects With Confirmed SARS-CoV-2
enthalten in:
ClinicalTrials.gov
| 2021
Wird geladen...
5
The Prevent Severe COVID-19 (PRESECO) Study : Favipiravir for Patients With Mild to Moderate Disease From Novel Coronavirus (COVID-19)
enthalten in:
ClinicalTrials.gov
| 2021
Wird geladen...
6
Efficacy of Different COVID-19 Vaccine Combinations in Inducing Long-term Humoral Immunity [PRIBIVAC] : Heterologous Prime-boost-boost Vaccine Combinations for Long-term Humoral and Cellular Immunity Against COVID-19
enthalten in:
ClinicalTrials.gov
| 2021
Wird geladen...
7
Favipiravir in High-risk COVID-19 Patients : Efficacy of Favipiravir in High Risk COVID-19 Patients: A Randomised, Open-label, Multicenter Clinical Trial
enthalten in:
ClinicalTrials.gov
| 2021
Wird geladen...
8
A Randomized Controlled Trial Assessing the Efficacy of Lianhua Qingwen as an Adjuvant Treatment in Patients With Mild Symptoms of COVID-19 : A Randomized Controlled Trial Assessing the Efficacy of Lianhua Qingwen as an Adjuvant Treatment in Patients With Mild Symptoms of COVID-19
enthalten in:
ClinicalTrials.gov
| 2021
Wird geladen...
9
Full Dose Heparin Vs. Prophylactic Or Intermediate Dose Heparin in High Risk COVID-19 Patients : Systemic Anticoagulation With Full Dose Low Molecular Weight Heparin (LMWH) Vs. Prophylactic or Intermediate Dose LMWH in High Risk COVID-19 Patients (HEP-COVID Trial)
enthalten in:
ClinicalTrials.gov
| 2021
Wird geladen...
10
OD-doxy-PNV-COVID-19 Old Drug " DOXY " for Prevention of New Virus " COVID-19 " : Covid-19 Infection Prophylaxis With Low Dose of Doxycycline and Zinc in Health Care Workers
enthalten in:
ClinicalTrials.gov
| 2021
Wird geladen...
1
2
3
4
5
Nächster »
[5]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Filter aufheben
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Erscheinungsjahr: 2019-2021
Filter aufheben
Thema: Phase: Phase 3
Filter aufheben
Thema: COVID-19
Medienart
42
Aufsätze
42
E-Artikel
42
E-Ressourcen
Zeitschriftentitel
42
ClinicalTrials.gov
Thema
42
610
COVID-19
Phase: Phase 3
42
Study Type: Interventional
23
Recruitment Status: Completed
12
Medical Condition: COVID-19
10
Medical Condition: Covid19
7
Recruitment Status: Recruiting
3
Coronavirus Infections
3
Infections
3
Recruitment Status: Not yet recruiting
3
Recruitment Status: Terminated
3
Recruitment Status: Withdrawn
2
Medical Condition: Coronavirus Infection
2
Medical Condition: SARS-CoV-2
2
Recruitment Status: Active, not recruiting
1
Anaphylaxis
1
Blood Coagulation Disorders
1
Communicable Diseases
1
Cytokine Release Syndrome
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
2019-2021
Erscheinungsjahr(e)
Von:
Bis:
Sprache
42
Englisch
Haven't found what you're looking for?
Wird geladen...